Report Detail
Global Polyarticular Juvenile Idiopathic Arthritis Drug Market Insights, Forecast to 2025
- RnM2983544 |
- 19 February, 2019 |
- Global |
- 118 Pages |
- QYResearch |
- Pharma & Healthcare
The global Polyarticular Juvenile Idiopathic Arthritis Drug market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Polyarticular Juvenile Idiopathic Arthritis Drug market based on company, product type, end user and key regions.
This report studies the global market size of Polyarticular Juvenile Idiopathic Arthritis Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Polyarticular Juvenile Idiopathic Arthritis Drug in these regions.
This research report categorizes the global Polyarticular Juvenile Idiopathic Arthritis Drug market by top players/brands, region, type and end user. This report also studies the global Polyarticular Juvenile Idiopathic Arthritis Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Biocon Ltd
Coherus BioSciences Inc
Livzon Pharmaceutical Group Inc
Momenta Pharmaceuticals Inc
Mycenax Biotech Inc
Oncobiologics Inc
Oncodesign SA
Panacea Biotec Ltd
Regeneron Pharmaceuticals Inc
Sandoz International GmbH
UCB SA
Market size by Product
Etanercept Biosimilar
Tocilizumab Biosimilar
Sarilumab
Adalimumab Biosimilar
Others
Market size by End User
Hospital
Clinic
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Polyarticular Juvenile Idiopathic Arthritis Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Polyarticular Juvenile Idiopathic Arthritis Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Polyarticular Juvenile Idiopathic Arthritis Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Polyarticular Juvenile Idiopathic Arthritis Drug submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Polyarticular Juvenile Idiopathic Arthritis Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Polyarticular Juvenile Idiopathic Arthritis Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Polyarticular Juvenile Idiopathic Arthritis Drug Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Market Size Growth Rate by Product
- 1.4.2 Etanercept Biosimilar
- 1.4.3 Tocilizumab Biosimilar
- 1.4.4 Sarilumab
- 1.4.5 Adalimumab Biosimilar
- 1.4.6 Others
- 1.5 Market by End User
- 1.5.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Market Size Growth Rate by End User
- 1.5.2 Hospital
- 1.5.3 Clinic
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Market Size
- 2.1.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue 2014-2025
- 2.1.2 Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales 2014-2025
- 2.2 Polyarticular Juvenile Idiopathic Arthritis Drug Growth Rate by Regions
- 2.2.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Regions
- 2.2.2 Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Manufacturers
- 3.1.1 Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Manufacturers
- 3.1.2 Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Manufacturers
- 3.1.3 Global Polyarticular Juvenile Idiopathic Arthritis Drug Market Concentration Ratio (CR5 and HHI)
- 3.2 Polyarticular Juvenile Idiopathic Arthritis Drug Revenue by Manufacturers
- 3.2.1 Polyarticular Juvenile Idiopathic Arthritis Drug Revenue by Manufacturers (2014-2019)
- 3.2.2 Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Share by Manufacturers (2014-2019)
- 3.3 Polyarticular Juvenile Idiopathic Arthritis Drug Price by Manufacturers
- 3.4 Polyarticular Juvenile Idiopathic Arthritis Drug Manufacturing Base Distribution, Product Types
- 3.4.1 Polyarticular Juvenile Idiopathic Arthritis Drug Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Polyarticular Juvenile Idiopathic Arthritis Drug Product Type
- 3.4.3 Date of International Manufacturers Enter into Polyarticular Juvenile Idiopathic Arthritis Drug Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Product
- 4.2 Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue by Product
- 4.3 Polyarticular Juvenile Idiopathic Arthritis Drug Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Polyarticular Juvenile Idiopathic Arthritis Drug Breakdown Data by End User
6 North America
- 6.1 North America Polyarticular Juvenile Idiopathic Arthritis Drug by Countries
- 6.1.1 North America Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Countries
- 6.1.2 North America Polyarticular Juvenile Idiopathic Arthritis Drug Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Polyarticular Juvenile Idiopathic Arthritis Drug by Product
- 6.3 North America Polyarticular Juvenile Idiopathic Arthritis Drug by End User
7 Europe
- 7.1 Europe Polyarticular Juvenile Idiopathic Arthritis Drug by Countries
- 7.1.1 Europe Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Countries
- 7.1.2 Europe Polyarticular Juvenile Idiopathic Arthritis Drug Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Polyarticular Juvenile Idiopathic Arthritis Drug by Product
- 7.3 Europe Polyarticular Juvenile Idiopathic Arthritis Drug by End User
8 Asia Pacific
- 8.1 Asia Pacific Polyarticular Juvenile Idiopathic Arthritis Drug by Countries
- 8.1.1 Asia Pacific Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Countries
- 8.1.2 Asia Pacific Polyarticular Juvenile Idiopathic Arthritis Drug Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Polyarticular Juvenile Idiopathic Arthritis Drug by Product
- 8.3 Asia Pacific Polyarticular Juvenile Idiopathic Arthritis Drug by End User
9 Central & South America
- 9.1 Central & South America Polyarticular Juvenile Idiopathic Arthritis Drug by Countries
- 9.1.1 Central & South America Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Countries
- 9.1.2 Central & South America Polyarticular Juvenile Idiopathic Arthritis Drug Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Polyarticular Juvenile Idiopathic Arthritis Drug by Product
- 9.3 Central & South America Polyarticular Juvenile Idiopathic Arthritis Drug by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Polyarticular Juvenile Idiopathic Arthritis Drug by Countries
- 10.1.1 Middle East and Africa Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Countries
- 10.1.2 Middle East and Africa Polyarticular Juvenile Idiopathic Arthritis Drug Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Polyarticular Juvenile Idiopathic Arthritis Drug by Product
- 10.3 Middle East and Africa Polyarticular Juvenile Idiopathic Arthritis Drug by End User
11 Company Profiles
- 11.1 Biocon Ltd
- 11.1.1 Biocon Ltd Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Biocon Ltd Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Biocon Ltd Polyarticular Juvenile Idiopathic Arthritis Drug Products Offered
- 11.1.5 Biocon Ltd Recent Development
- 11.2 Coherus BioSciences Inc
- 11.2.1 Coherus BioSciences Inc Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Coherus BioSciences Inc Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Coherus BioSciences Inc Polyarticular Juvenile Idiopathic Arthritis Drug Products Offered
- 11.2.5 Coherus BioSciences Inc Recent Development
- 11.3 Livzon Pharmaceutical Group Inc
- 11.3.1 Livzon Pharmaceutical Group Inc Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Livzon Pharmaceutical Group Inc Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Livzon Pharmaceutical Group Inc Polyarticular Juvenile Idiopathic Arthritis Drug Products Offered
- 11.3.5 Livzon Pharmaceutical Group Inc Recent Development
- 11.4 Momenta Pharmaceuticals Inc
- 11.4.1 Momenta Pharmaceuticals Inc Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Momenta Pharmaceuticals Inc Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Momenta Pharmaceuticals Inc Polyarticular Juvenile Idiopathic Arthritis Drug Products Offered
- 11.4.5 Momenta Pharmaceuticals Inc Recent Development
- 11.5 Mycenax Biotech Inc
- 11.5.1 Mycenax Biotech Inc Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Mycenax Biotech Inc Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Mycenax Biotech Inc Polyarticular Juvenile Idiopathic Arthritis Drug Products Offered
- 11.5.5 Mycenax Biotech Inc Recent Development
- 11.6 Oncobiologics Inc
- 11.6.1 Oncobiologics Inc Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Oncobiologics Inc Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Oncobiologics Inc Polyarticular Juvenile Idiopathic Arthritis Drug Products Offered
- 11.6.5 Oncobiologics Inc Recent Development
- 11.7 Oncodesign SA
- 11.7.1 Oncodesign SA Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Oncodesign SA Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Oncodesign SA Polyarticular Juvenile Idiopathic Arthritis Drug Products Offered
- 11.7.5 Oncodesign SA Recent Development
- 11.8 Panacea Biotec Ltd
- 11.8.1 Panacea Biotec Ltd Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Panacea Biotec Ltd Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Panacea Biotec Ltd Polyarticular Juvenile Idiopathic Arthritis Drug Products Offered
- 11.8.5 Panacea Biotec Ltd Recent Development
- 11.9 Regeneron Pharmaceuticals Inc
- 11.9.1 Regeneron Pharmaceuticals Inc Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Regeneron Pharmaceuticals Inc Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Regeneron Pharmaceuticals Inc Polyarticular Juvenile Idiopathic Arthritis Drug Products Offered
- 11.9.5 Regeneron Pharmaceuticals Inc Recent Development
- 11.10 Sandoz International GmbH
- 11.10.1 Sandoz International GmbH Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Sandoz International GmbH Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Sandoz International GmbH Polyarticular Juvenile Idiopathic Arthritis Drug Products Offered
- 11.10.5 Sandoz International GmbH Recent Development
- 11.11 UCB SA
12 Future Forecast
- 12.1 Polyarticular Juvenile Idiopathic Arthritis Drug Market Forecast by Regions
- 12.1.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales Forecast by Regions 2019-2025
- 12.1.2 Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Forecast by Regions 2019-2025
- 12.2 Polyarticular Juvenile Idiopathic Arthritis Drug Market Forecast by Product
- 12.2.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales Forecast by Product 2019-2025
- 12.2.2 Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Forecast by Product 2019-2025
- 12.3 Polyarticular Juvenile Idiopathic Arthritis Drug Market Forecast by End User
- 12.4 North America Polyarticular Juvenile Idiopathic Arthritis Drug Forecast
- 12.5 Europe Polyarticular Juvenile Idiopathic Arthritis Drug Forecast
- 12.6 Asia Pacific Polyarticular Juvenile Idiopathic Arthritis Drug Forecast
- 12.7 Central & South America Polyarticular Juvenile Idiopathic Arthritis Drug Forecast
- 12.8 Middle East and Africa Polyarticular Juvenile Idiopathic Arthritis Drug Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Polyarticular Juvenile Idiopathic Arthritis Drug Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Polyarticular Juvenile Idiopathic Arthritis Drug . Industry analysis & Market Report on Polyarticular Juvenile Idiopathic Arthritis Drug is a syndicated market report, published as Global Polyarticular Juvenile Idiopathic Arthritis Drug Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Polyarticular Juvenile Idiopathic Arthritis Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
